Zacks: Analysts Expect Cotiviti Holdings Inc (COTV) to Announce $0.43 Earnings Per Share

Analysts expect Cotiviti Holdings Inc (NYSE:COTV) to announce $0.43 earnings per share for the current quarter, according to Zacks. Eight analysts have issued estimates for Cotiviti’s earnings, with the highest EPS estimate coming in at $0.44 and the lowest estimate coming in at $0.42. Cotiviti posted earnings of $0.39 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 10.3%. The company is scheduled to issue its next earnings report on Wednesday, February 28th.

According to Zacks, analysts expect that Cotiviti will report full-year earnings of $1.53 per share for the current financial year, with EPS estimates ranging from $1.53 to $1.54. For the next fiscal year, analysts expect that the company will report earnings of $1.69 per share, with EPS estimates ranging from $1.62 to $1.89. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that cover Cotiviti.

Cotiviti (NYSE:COTV) last released its quarterly earnings results on Tuesday, October 31st. The business services provider reported $0.39 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.38 by $0.01. The company had revenue of $174.20 million for the quarter, compared to analyst estimates of $174.01 million. Cotiviti had a net margin of 13.86% and a return on equity of 13.61%. The firm’s revenue was up 11.5% on a year-over-year basis. During the same quarter last year, the business earned $0.36 earnings per share.

Several analysts recently commented on the stock. BidaskClub upgraded shares of Cotiviti from a “sell” rating to a “hold” rating in a research report on Tuesday, September 26th. Citigroup initiated coverage on shares of Cotiviti in a research report on Thursday, January 4th. They issued a “buy” rating on the stock. Zacks Investment Research lowered shares of Cotiviti from a “hold” rating to a “strong sell” rating in a research report on Tuesday, January 2nd. Robert W. Baird reiterated a “buy” rating and issued a $44.00 target price on shares of Cotiviti in a research report on Friday, November 3rd. Finally, Mitsubishi UFJ Financial Group initiated coverage on shares of Cotiviti in a research report on Thursday, September 21st. They issued an “overweight” rating and a $42.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $40.38.

Cotiviti (NYSE:COTV) traded down $0.46 during mid-day trading on Thursday, reaching $33.85. 352,982 shares of the company traded hands, compared to its average volume of 403,297. The firm has a market capitalization of $3,126.69, a price-to-earnings ratio of 34.90, a PEG ratio of 1.72 and a beta of 0.43. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.73. Cotiviti has a 52 week low of $30.84 and a 52 week high of $45.97.

In other Cotiviti news, COO David Beaulieu sold 5,000 shares of Cotiviti stock in a transaction dated Monday, October 16th. The shares were sold at an average price of $35.00, for a total transaction of $175,000.00. Following the transaction, the chief operating officer now directly owns 43,133 shares of the company’s stock, valued at $1,509,655. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO J Douglas Williams sold 16,655 shares of Cotiviti stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $31.25, for a total transaction of $520,468.75. Following the transaction, the chief executive officer now directly owns 2,776,606 shares in the company, valued at $86,768,937.50. The disclosure for this sale can be found here. Insiders have sold 148,240 shares of company stock worth $4,906,718 over the last ninety days. 15.80% of the stock is owned by insiders.

A number of hedge funds have recently modified their holdings of the business. Great West Life Assurance Co. Can purchased a new stake in shares of Cotiviti in the 2nd quarter valued at approximately $107,000. BNP Paribas Arbitrage SA raised its stake in shares of Cotiviti by 553.5% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 3,137 shares of the business services provider’s stock valued at $117,000 after acquiring an additional 2,657 shares during the period. Strategic Global Advisors LLC purchased a new stake in shares of Cotiviti in the 3rd quarter valued at approximately $200,000. Pacer Advisors Inc. raised its stake in shares of Cotiviti by 138.9% in the 2nd quarter. Pacer Advisors Inc. now owns 5,642 shares of the business services provider’s stock valued at $210,000 after acquiring an additional 3,280 shares during the period. Finally, Quantbot Technologies LP raised its stake in shares of Cotiviti by 34.5% in the 2nd quarter. Quantbot Technologies LP now owns 6,420 shares of the business services provider’s stock valued at $238,000 after acquiring an additional 1,645 shares during the period. 86.18% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/06/zacks-analysts-expect-cotiviti-holdings-inc-cotv-to-announce-0-43-earnings-per-share.html.

Cotiviti Company Profile

Cotiviti Holdings, Inc is a provider of analytics-driven payment accuracy solutions. The Company focuses primarily on the healthcare sector. The Company operates through two segments: Healthcare, and Global Retail and Other. Through its Healthcare segment, the Company offers prospective and retrospective claims accuracy solutions to healthcare payers in the United States.

Get a free copy of the Zacks research report on Cotiviti (COTV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cotiviti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply